Systemic inflammation following cardiopulmonary bypass for mitral valve replacement: the role of non-steroidal anti-inflammatory drugs parecoxib and flurbiprofen.
Phase of Trial: Phase IV
Latest Information Update: 21 May 2012
At a glance
- Drugs Flurbiprofen (Primary) ; Parecoxib (Primary)
- Indications Postoperative pain
- Focus Pharmacodynamics
- 01 Nov 2010 New trial record